Successful Use of Photodynamic Therapy for Treatment of Palbociclib-Induced Periorificial Dermatitis
References
Sollena P, Vasiliki N, Kotteas E, et al. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force "Dermatology for Cancer Patients" International Study. Cancers (Basel). 2023 Jul 18;15(14):3658. doi: 10.3390/cancers15143658. PMID: 37509319; PMCID: PMC10377938.
Fattore D, Fabbrocini G, Sibaud V, Sollena P. The urgent need of dermatologists for cancer patients in Italy. Ital J Dermatol Venerol. 2023 Jun;158(3):274-275. doi: 10.23736/S2784-8671.23.07531-X. Epub 2023 May 10. PMID: 37162245.
Searle T, Ali FR, Al-Niaimi F. Perioral dermatitis: Diagnosis, proposed etiologies, and management. J Cosmet Dermatol. 2021 Dec;20(12):3839-3848. doi: 10.1111/jocd.14060. Epub 2021 Mar 16. PMID: 33751778
Amigo M, Hoffman K, Chung C, et al. Presentation and management of diverse cutaneous reactions after cyclin-dependent kinase 4/6 inhibitor use. J Am Acad Dermatol. 2022 Jun;86(6):1346-1348. doi: 10.1016/j.jaad.2021.04.092. Epub 2021 May 5. PMID: 33961922.
Richey DF, Hopson B. Photodynamic therapy for perioral dermatitis. J Drugs Dermatol. 2006 Feb;5(2 Suppl):12-6. PMID: 16485876.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Davide Fattore, Giuseppe Lauletta, Matteo Megna, Nello Tommasino
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.